| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |